Urticaria and Angioedema

143

Severe Tongue Swellings In Hereditary Angioedema With A Specific Mutation In The Plasminogen Gene
Konrad Bork, MD Karin Wulff Lars Steinmueller-Magin Ingrid Braenne Guenther Witzke Jochen Hardt

144

Reduced D-dimer Levels In C1-esterase-inhibitor Hereditary Angioedema (C1-INH-HAE) Patients Treated With Subcutaneous C1-esterase-inhibitor (C1-INH[SC]): Findings From The COMPACT Study
Avner Reshef Marco Cicardi, MD Bruce L. Zuraw, MD Timothy Craig, DO, FAAAAI, AOA Hilary Longhurst Teresa Caballero, MD PhD Henriette Farkas John-Philip Lawo Iris Jacobs, MD Ingo Pragst, MD

145

Initiation of Prophylactic Treatment with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) for Prevention of Hereditary Angioedema (HAE) Attacks and Onset of Effect: Findings from the Phase III COMPACT Study
Huamin Henry Li, MD PhD FAAAAI Marc A. Riedl, MD MS Timothy Craig, DO, FAAAAI, AOA Hilary J. Longhurst, MD Marco Cicardi, MD Bruce L. Zuraw, MD Henrike Feuersenger, PhD

146

Prevention of Attacks of Hereditary Angioedema (HAE) with Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) by Anatomical Location: Results From the Phase III COMPACT Study (NCT01912456)
Donald S. Levy, MD Joseph Chiao, MD Henrike Feuersenger, PhD Timothy Craig, DO, FAAAAI, AOA Hilary J. Longhurst, MD Marco Cicardi, MD Bruce L. Zuraw, MD Iris Jacobs, MD

147

The Autologous Serum Skin Test as a Prognostic Factor for the Severity and Duration of Chronic Urticaria after five years of Follow-up
Karen Milena Lozano Mosquera Beatriz Moya Camacho Ruth Mielgo Ballesteros Alicia Enriquez Matas, MD Miguel Angel Díaz Consuelo Fernández Rodríguez Lys Herraez

148

In silico Analysis Of Alterations In ANGPT1 Gene Supports A New Pathway Responsible To Mediate Hereditary Angioedema In Brazilian Patients With No Mutations In SERPING1 And F12 Genes.
Nathália Cagini, MsC Camila Lopez Veronez, PhD Bruna Franca Azevedo Rosemeire Navickas Constantino-Silva, PhD Renan Paulo Martin, PhD Jane da Silva, PhD Anete S. Grumach, PhD João Bosco Pesquero, PhD

149

Cinryze is Efficacious for Hereditary Angioedema (HAE) Attack Prevention In Pediatric Patients: Final Phase 3 Efficacy And Safety Results
Emel Aygören-Pürsün, MD Daniel F. Soteres, MD FAAAAI Sandra Nieto–Martinez Jim Christensen, MD FAAAAI Kraig W. Jacobson, MD FAAAAI Dumitru Moldovan, MD, PhD Arthur Van Leerberghe Tom Tang Peng Lu, MD, PhD Inmaculada Martinez-Saguer, MD

150

Efficacy of lanadelumab in patients switching from long-term prophylaxis with C1-inhibitor (C1-INH): results from the phase 3 HELP Study
Douglas T. Johnston, DO FAAAAI John T. Anderson, MD Jennifer Schranz, MD Christina Nurse, PhD Marco Cicardi, MD

151

Consistent Lanadelumab Treatment Effect In Patients With Hereditary Angioedema (HAE) Regardless Of Baseline Attack Frequency In The Phase 3 HELPStudy
Marc A. Riedl, MD MS Raffi Tachdjian, MD MPH Jennifer Schranz, MD Christina Nurse, PhD Jonathan A. Bernstein, MD FAAAAI

152

Lanadelumab Markedly Improves Health-related Quality of Life in Hereditary Angioedema Patients in the HELP Study
William R. Lumry, MD FAAAAI Karsten Weller, MD Markus Magerl, MD Jennifer Schranz, MD Gagan Jain Helen Doll Marcus Maurer, MD

153

Cooperative Effects between CRTh2 and CCR3 on Eosinophils and Basophils in Chronic Spontaneous Urticaria
Eric T. Oliver, MD Kristin L. Chichester, MS Sarbjit Singh Saini, MD FAAAAI

154

Drug-induced urticaria (DIU) and angioedema in Latin American Countries
Edgardo J. Jares, MD Mario Sanchez-Borges, MD FAAAAI R Maximiliano Gomez, MD PhD Carlos D. Serrano, MD Luis Felipe C. Ensina, MD, PhD Ivan Cherrez- Ojeda, MD Jonathan A. Bernstein, MD FAAAAI Alicia Mabel De Falco, MD Mabel Noemi Cuello, MD Blanca Maria Del Refugio Morfin Maciel, MD FAAAAI Alfredo Arias Cruz, MD FAAAAI Ricardo Cardona Villa Sandra Nora González- Diaz, MD PhD FAAAAI FACAAI, EAACI Alejandra Macias-Weinmann, MD Silvana Beatriz Monsell Galie E. Mimessi, MD Raul Adolfo Salvatierra, MD Andrea Zanacchi Luis F Ramirez Zuluaga Norma Susana de Barayazarra, MD Juan F. Schuhl, MD FAAAAI Paola A. Toche Pinaud Susana Diez Miguel Angel Vinuesa, MD Mara Morelo Rocha Felix Ada Del Castillo Mendez, MD

155

Validity and Responsiveness of Urticaria Activity and Impact Measure (U-AIM), a New Patient-Reported Tool to Assess Disease Activity and Impact in Patients with Chronic Spontaneous/Idiopathic Urticaria (CSU/CIU)
Marcus Maurer, MD Evgeniya N. Antonova, PhD, MS Susan D. Mathias, MPH Ross D. Crosby, PhD James L. Zazzali, PhD, MPH

156

Real-life experience with recombinant human C1-inhibitor in treatment of hereditary angioedema with C1-inhibitor deficiency
Henriette Farkas, MD, PhD, DSc Nora Veszeli Kinga V Kőhalmi Lilian Varga

157

Association Between Systemic Lupus Erythematosus and Angioedema in Hospital Settings: A Nationwide Study
Xiaowen Fan Yiming Luo Jiehui Xu

158

Use Of Central Venous Access Devices (CVAD) And Associated Outcomes In Hereditary Angioedema (HAE) Patients: Findings From A Large United States (US) Claims Database
Douglas J. Watson Marc A. Riedl, MD MS Aleena Banerji, MD Michael E. Manning Earl Burrell Namita Joshi Dipen Patel Thomas Machnig Ming-Hui Tai

159

Genetic variants of VDR and vitamin D insufficiency are associated with chronic spontaneous urticaria in Colombian adults.
Eduardo Egea, MD, PhD Luis Fang, DDS, MSc. Nicole Pereira-Sanandres Fernando R De la cruz-Lopez Sofia Moreno-Woo Gloria Garavito-De Egea, MD, PhD

160

Clinical Characteristics of Patients in Allergy Clinic with Presumed Diagnosis of Mast Cell Activation Syndrome (MCAS)
Kristine K Arndt, MD Ravi K. Viswanathan, MD Sameer K Mathur, MD PhD FAAAAI

161

Subgroup Analysis Identifies Differences Between Sexes In How CIU Patients Respond To Omalizumab
Sarbjit Singh Saini, MD FAAAAI Benjamin L. Trzaskoma, MS Noelle M. Griffin, PhD

162

The influence of individualized treatment on the quality of life (QoL) in 100 patients with Hereditary Angioedema (HAE C1-INH)
Inmaculada Martinez Saguer Carmen Escuriola Ettingshausen Zeynep Gutowski Richard Linde

163

Development of a New Tool for Assessing Health-Related Quality of Life (QoL) in Patients with Hereditary Angioedema (HAE): The United States HAE Association (HAEA)-QoL
Sandra C. Christiansen, MD FAAAAI Paula J. Busse, MD FAAAAI Janette Birmingham, M.S. Aleena Banerji, MD William R. Lumry, MD FAAAAI Bruce L. Zuraw, MD

164

Subcutaneous (SC) vs Intravenous (IV) C1-esterase-inhibitor (C1-INH) Replacement Treatment For The Prevention Of Attacks Of Hereditary Angioedema (HAE): A Population-based Exposure‑response Analysis
Bruce L. Zuraw, MD Marco Cicardi, MD Timothy Craig, DO, FAAAAI, AOA Hilary J. Longhurst, MD William R. Lumry Jonathan A. Bernstein, MD FAAAAI Ying Zhang Dipti K. Pawaskar, PhD

165

Long term efficacy of Omalizumab for patients with refractory chronic urticaria and angioedema
Zhen Ren, MD, Ph.D H. James Wedner, MD FAAAAI

166

Angioedema in patients with chronic spontaneous urticaria: assessment of disease severity and response to treatment.
João Paulo de Assis, MD Gabriella Melo Fontes Silva Dias, MD Claudia Castilho Mouco Andressa Zanandréa Raisa Borges Castro, MD Jorge Kalil, MD, PhD Antonio Abilio Motta Rosana C. Agondi, MD, PhD

167

Safety of Recombinant Human C1 Esterase Inhibitor for Hereditary Angioedema Attacks in Pregnant Women
Dumitru Moldovan, MD, PhD Jonathan A. Bernstein, MD FAAAAI Roman Hakl, MD Luca Bellizzi Anurag Relan

168

Characterization Of Hereditary Angioedema Attacks Requiring Reinjection Of Icatibant: Findings From The Icatibant Outcome Survey
Irmgard Andresen, MD Hilary J. Longhurst, MD Laurence Bouillet, MD PhD Teresa Caballero, MD PhD Andrea Zanichelli, MD Marcus Maurer, MD Anete S. Grumach, PhD Anette Bygum, MD Jaco Botha Werner Aberer, MD

169

Healthcare Resource Utilization Among a US Cohort Treated for Hereditary Angioedema, 2010-2015
Raffi Tachdjian Karin Johnson Deborah Casso Susan Oliveria Giovanna Devercelli Gagan Jain

170

The Urticaria Control Test as a Tool for Monitoring Chronic Idiopathic/Spontaneous Urticaria Treatment: Results From XTEND-CIU, a 48-Week, Randomized, Placebo-controlled Study
Allen P. Kaplan, MD FAAAAI Thomas B. Casale, MD FAAAAI Jonathan A. Bernstein, MD FAAAAI Michael Holden, MD, MS Ahmar Iqbal, MD Benjamin L. Trzaskoma, MS Marcus Maurer, MD

171

Serum levels of leptin, adiponectin and vitamin D in Colombian adults with chronic urticaria.
Luis Fang, DDS, MSc. Eduardo Egea, MD, PhD Nicole Pereira-Sanandres Fernando R De la cruz-Lopez Sofia Moreno-Woo Gloria Garavito-De Egea, MD, PhD

172

CHRONIC URTICARIA IN CHILDREN: ARE THERE DIFFERENCES IN COMPARISON WITH ADULTS?
Pamela P. Silva Lais Gomes Japiassú Patrícia Guerzet Ayres Bastos Luis Felipe C. Ensina, MD, PhD Ines Cristina Camelo Nunes Dirceu Sole, MD PhD FAAAAI Barbara Martins de Aquino Chayanne Andrade de Araújo Alex Eustáquio de Lacerda Marina Medeiros Caputo

173

Distinguishing Features of Patients with Comorbid Urticaria and Angioedema Versus Isolated Urticaria and Angioedema
Jennifer E. Boeckman, DO Shari V. Montandon, DO Andrej Petrov, MD Merritt L. Fajt, MD FAAAAI

174

Omalizumab for management of chronic urticaria in a pediatric population: a case-series
Jason El Bilali, MSc Sofianne Gabrielli, MSc Greg Shand, BSc, MSc Elena Netichoprouk Moshe Ben-Shoshan, MD, MSc

175

Clinical evolution of patients with chronic spontaneous urticaria steroid-dependent.
Raisa Borges Castro, MD Rafaella amorim gaia Duarte, MD Andressa Zanandréa Claudia Castilho Mouco Joao Paulo de Assis Gabriella Melo Fontes Silva Dias, MD Franciane Almonfrey, MD Rebeca M. Brugnolli Jorge Kalil, MD,PhD Rosana C. Agondi, MD, PhD

176

Burden Of Hereditary Angioedema In The Quality Of Life Among Puerto Ricans
Yanira M. Arce-Ayala, MD Sylvette Nazario, MD Cristina J. Ramos-Romey, MD

177

Acute Respiratory Reactions Triggered by NSAIDs in Patients With Chronic Spontaneous Urticaria Exacerbated by NSAIDs
Mariele Lopes Pamella Diogo-Salles Jorge Kalil, MD, PhD Antonio Abilio Motta Rosana C. Agondi, MD, PhD

178

Long-Term Prophylaxis with Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: Is Intramuscular Administration an Option?
Anna Valerieva Borislava Krusheva, MD Maria Staevska

179

Pharmacokinetic Profile of Subcutaneous C1-Esterase Inhibitor (C1-INH [SC]) in Adolescent and Adult Patients with Hereditary Angioedema (HAE)
Dipti K. Pawaskar, PhD Iris Jacobs, MD Ingo Pragst, MD Henrike Feuersenger, PhD

180

Burden of Hereditary Angioedema: Findings From a US Patient Survey
Giovanna Devercelli Kimberly Davis Michelle Brown Kelly Hollis Shannon Hunter Janet Long Gagan Jain Aleena Banerji

181

Is There a Difference in Omalizumab Treatment Response in Patients With Chronic Autoimmune Urticaria vs Chronic Spontaneous Urticaria?
Kiranjit K. Khalsa, MD Gargi Patel Natalia Testo, MD Muhammad A. Pasha, MD FAAAAI

182

The Predictability of Attacks in Patients with Hereditary Angioedema
Markus AK Magerl, MD Marc A. Riedl, MD MS Scott D. Newcomer, MS Dylan Supina, PhD Girishanthy Krishnarajah, MPH, MBA/MS, PHD

183

Effect of Antileukotriene Agents in Chronic Urticaria-Isolated Angioedema Phenotype
Ayobami T Akenroye, MD MPH Conor McEwan Sarbjit Singh Saini, MD FAAAAI

184

Long-term Safety Outcomes of Prekallikrein Deficiency: A Systematic Literature Review
Moshe Vardi Antonio Girolami Dan Sexton Catherine Rolland Jonathan A. Bernstein, MD FAAAAI

185

Is Intramuscular Administration of Recombinant Human C1-Inhibitor an Alternative for the Treatment of Acute Attacks in Patients with Hereditary Angioedema?
Maria Staevska Anna Valerieva

186

Chronic spontaneous urticaria and autoimmunity: a follow up study of patients with chronic urticaria for 16 years.
Claudia Castilho Mouco Andressa Zanandréa João Paulo de Assis, MD Raisa Borges Castro, MD Gabriella Melo Fontes Silva Dias, MD Jorge Kalil, MD, PhD Antonio Abilio Motta Rosana C. Agondi, MD, PhD

187

An Observational Study to Understand Patient and Physician Communication in Hereditary Angioedema (HAE)
Gagan Jain Lauren Walter Carolyn Reed Pattie O’Donnell

188

Etiology of Chronic Urticaria in Latin America, Ecuadorian experience.
Annia Cherrez Emanuel Vanegas Miguel Felix Valeria Mata Leonardo Greiding, MD FAAAAI René Maximiliano Gómez, SLaai Ivan Cherrez

189

Cold contact urticaria: association of positive ice cube test and autoimmunity
Rebeca M. Brugnolli Pamella Diogo Salles Larissa P Cau, MD Raisa B Castro Jorge Elias Kalil Filho, MD, PhD Antonio Abilio Motta Rosana C. Agondi, MD, PhD